{"disease":{"id":"lassa-fever","name":"lassa fever"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655561","title":"Lassa Fever Clinical Course and Prognostic Factors in Nigeria","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Alliance for International Medical Action","has_results":false},{"nct_id":"NCT04093076","title":"Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":false},{"nct_id":"NCT04285034","title":"Cardiovascular Function and Ribavirin PK/PD in Lassa Fever in Lassa Fever","phase":"","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03805984","title":"Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":false},{"nct_id":"NCT04907682","title":"Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Bernhard Nocht Institute for Tropical Medicine","has_results":false},{"nct_id":"NCT03889106","title":"Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"University of Oxford","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}